These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25238173)

  • 1. Structure-activity relationships of sugar-based peptidomimetics as modulators of amyloid β-peptide early oligomerization and fibrillization.
    Kaffy J; Brinet D; Soulier JL; Khemtémourian L; Lequin O; Taverna M; Crousse B; Ongeri S
    Eur J Med Chem; 2014 Oct; 86():752-8. PubMed ID: 25238173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designed Glycopeptidomimetics Disrupt Protein-Protein Interactions Mediating Amyloid β-Peptide Aggregation and Restore Neuroblastoma Cell Viability.
    Kaffy J; Brinet D; Soulier JL; Correia I; Tonali N; Fera KF; Iacone Y; Hoffmann AR; Khemtémourian L; Crousse B; Taylor M; Allsop D; Taverna M; Lequin O; Ongeri S
    J Med Chem; 2016 Mar; 59(5):2025-40. PubMed ID: 26789783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicomponent, fragment-based synthesis of polyphenol-containing peptidomimetics and their inhibiting activity on beta-amyloid oligomerization.
    Lambruschini C; Galante D; Moni L; Ferraro F; Gancia G; Riva R; Traverso A; Banfi L; D'Arrigo C
    Org Biomol Chem; 2017 Nov; 15(44):9331-9351. PubMed ID: 29087411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro monitoring of amyloid β-peptide oligomerization by Electrospray differential mobility analysis: An alternative tool to evaluate Alzheimer's disease drug candidates.
    Brinet D; Gaie-Levrel F; Delatour V; Kaffy J; Ongeri S; Taverna M
    Talanta; 2017 Apr; 165():84-91. PubMed ID: 28153323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sugar-based peptidomimetics inhibit amyloid β-peptide aggregation.
    Dorgeret B; Khemtémourian L; Correia I; Soulier JL; Lequin O; Ongeri S
    Eur J Med Chem; 2011 Dec; 46(12):5959-69. PubMed ID: 22027101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of fibril formation by a beta-sheet breaker peptide ligand: an electrochemical approach.
    Veloso AJ; Kerman K
    Bioelectrochemistry; 2012 Apr; 84():49-52. PubMed ID: 21967982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved capillary electrophoresis method for in vitro monitoring of the challenging early steps of Aβ1-42 peptide oligomerization: application to anti-Alzheimer's drug discovery.
    Brinet D; Kaffy J; Oukacine F; Glumm S; Ongeri S; Taverna M
    Electrophoresis; 2014 Dec; 35(23):3302-9. PubMed ID: 25219962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation on the influence of (Z)-3-(2-(3-chlorophenyl)hydrazono)-5,6-dihydroxyindolin-2-one (PT2) on β-amyloid(1-40) aggregation and toxicity.
    Catto M; Arnesano F; Palazzo G; De Stradis A; Calò V; Losacco M; Purgatorio R; Campagna F
    Arch Biochem Biophys; 2014 Oct; 560():73-82. PubMed ID: 25051344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Hairpin mimics containing a piperidine-pyrrolidine scaffold modulate the β-amyloid aggregation process preserving the monomer species.
    Pellegrino S; Tonali N; Erba E; Kaffy J; Taverna M; Contini A; Taylor M; Allsop D; Gelmi ML; Ongeri S
    Chem Sci; 2017 Feb; 8(2):1295-1302. PubMed ID: 28451272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrapeptidic molecular hydrogels: self-assembly and co-aggregation with amyloid fragment Aβ1-40.
    Tena-Solsona M; Miravet JF; Escuder B
    Chemistry; 2014 Jan; 20(4):1023-31. PubMed ID: 24338754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembly pathways of E22Δ-type amyloid β peptide mutants generated from non-aggregative O-acyl isopeptide precursors.
    Sohma Y; Wang H; Taniguchi A; Hirayama Y; Kakizawa T; Yamasaki M; Mukai H; Kiso Y
    Bioorg Med Chem; 2011 Jun; 19(12):3787-92. PubMed ID: 21612934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidomimetics That Inhibit and Partially Reverse the Aggregation of Aβ
    Stark T; Lieblein T; Pohland M; Kalden E; Freund P; Zangl R; Grewal R; Heilemann M; Eckert GP; Morgner N; Göbel MW
    Biochemistry; 2017 Sep; 56(36):4840-4849. PubMed ID: 28841311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual and In Vitro Screens Reveal a Potential Pharmacophore that Avoids the Fibrillization of Aβ1-42.
    Hernández-Rodríguez M; Correa-Basurto J; Nicolás-Vázquez MI; Miranda-Ruvalcaba R; Benítez-Cardoza CG; Reséndiz-Albor AA; Méndez-Méndez JV; Rosales-Hernández MC
    PLoS One; 2015; 10(7):e0130263. PubMed ID: 26172152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charged surfactants induce a non-fibrillar aggregation pathway of amyloid-beta peptide.
    Loureiro JA; Rocha S; Pereira Mdo C
    J Pept Sci; 2013 Sep; 19(9):581-7. PubMed ID: 23922329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laser-induced liquid bead ion desorption mass spectrometry: an approach to precisely monitor the oligomerization of the β-amyloid peptide.
    Cernescu M; Stark T; Kalden E; Kurz C; Leuner K; Deller T; Göbel M; Eckert GP; Brutschy B
    Anal Chem; 2012 Jun; 84(12):5276-84. PubMed ID: 22594938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New mimetic peptides inhibitors of Αβ aggregation. Molecular guidance for rational drug design.
    Barrera Guisasola EE; Andujar SA; Hubin E; Broersen K; Kraan IM; Méndez L; Delpiccolo CM; Masman MF; Rodríguez AM; Enriz RD
    Eur J Med Chem; 2015 May; 95():136-52. PubMed ID: 25805447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the behaviour of β-amyloid peptide variants during oligomerization and fibrillation.
    Shi JM; Zhang L; Liu EQ
    J Pept Sci; 2017 Nov; 23(11):810-817. PubMed ID: 28795459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solvent exposure of Tyr10 as a probe of structural differences between monomeric and aggregated forms of the amyloid-β peptide.
    Aran Terol P; Kumita JR; Hook SC; Dobson CM; Esbjörner EK
    Biochem Biophys Res Commun; 2015 Dec; 468(4):696-701. PubMed ID: 26551456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship for (+)-taxifolin isolated from silymarin as an inhibitor of amyloid β aggregation.
    Sato M; Murakami K; Uno M; Ikubo H; Nakagawa Y; Katayama S; Akagi K; Irie K
    Biosci Biotechnol Biochem; 2013; 77(5):1100-3. PubMed ID: 23649236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides, Peptidomimetics, and Carbohydrate-Peptide Conjugates as Amyloidogenic Aggregation Inhibitors for Alzheimer's Disease.
    Ryan P; Patel B; Makwana V; Jadhav HR; Kiefel M; Davey A; Reekie TA; Rudrawar S; Kassiou M
    ACS Chem Neurosci; 2018 Jul; 9(7):1530-1551. PubMed ID: 29782794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.